Ashwani K. Dhingra
Yamunanagar, HR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Corrigendum to: Recent Developments in Oral Drug Delivery of Prokinetic Agents: Nanoparticles and Beyond.
Journal: Current drug delivery
Published: March 13, 2026
Palladium-catalysed synthesis of small-molecule epigenetic inhibitors as anticancer therapeutics.
Journal: Journal of enzyme inhibition and medicinal chemistry
Published: February 16, 2026
Recent advances in small molecule ATR kinase inhibitors as anticancer agents.
Journal: Future medicinal chemistry
Published: January 28, 2026
Formulation, Development, and In vitro Evaluation of Sustained Release Buccal Films for Optimized Memantine Therapy.
Journal: Drug metabolism and bioanalysis
Published: November 16, 2025
Regenerative Approaches in Type 1 Diabetes: β-cell Replacement and Emerging Therapeutics.
Journal: Recent advances in inflammation & allergy drug discovery
Published: September 22, 2025
Neuroinflammatory and Synaptic Roles of Glial Cells in Autism Spectrum Disorder.
Journal: CNS & neurological disorders drug targets
Published: September 22, 2025
Hydrogel-based Advances in Dermatological Therapy: Insights from Patents and Clinical Research.
Journal: Reviews on recent clinical trials
Published: September 22, 2025
Bioactive Peptides: Production Strategies, Biological Activities, and Emerging Therapeutic Applications.
Journal: Protein and peptide letters
Published: August 16, 2025
Antiurolithiatic Potential of Colocasia esculenta Tubers: An Integrative In Silico, In Vitro, and In Vivo Evaluation.
Journal: Anti-inflammatory & anti-allergy agents in medicinal chemistry
Published: August 14, 2025
Targeting Autoimmunity in Myasthenia Gravis: From Conventional to Novel Therapeutic Approaches.
Journal: Protein and peptide letters
Published: August 14, 2025
Targeting Autoimmunity in Type 1 Diabetes: Emerging Immunomodulatory Therapies.
Journal: Current topics in medicinal chemistry
Published: August 14, 2025
Pharmacological Breakthroughs with Extracellular Vesicles-Based Nanomedicine: A Targeted Strategy to Cross the Blood-Brain Barrier in Alzheimer's Disease.
Journal: CNS & neurological disorders drug targets
Published: May 29, 2025
Last Updated: 09/26/2026